Biosenta Inc.
ZRO
CNSX
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 600.00 | 700.00 | 600.00 | 1.00K | 900.00 |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 600.00 | 700.00 | 600.00 | 1.00K | 900.00 |
| Cost of Revenue | 3.00K | 3.00K | 26.40K | 23.90K | 23.80K |
| Gross Profit | -2.30K | -2.30K | -25.90K | -23.00K | -23.00K |
| SG&A Expenses | 1.05M | 1.05M | 977.00K | 829.30K | 767.30K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.10M | 1.10M | 1.05M | 894.00K | 873.90K |
| Operating Income | -1.10M | -1.10M | -1.05M | -893.00K | -873.00K |
| Income Before Tax | -4.86M | -4.69M | 371.30K | 518.20K | -930.10K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.86 | -4.69 | 0.37 | 0.52 | -0.93 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.86M | -4.69M | 371.30K | 518.20K | -930.10K |
| EBIT | -1.10M | -1.10M | -1.05M | -893.00K | -873.00K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.15 | -0.14 | 0.04 | 0.04 | -0.03 |
| Normalized Basic EPS | -0.03 | -0.03 | -0.03 | -0.03 | -0.03 |
| EPS Diluted | -0.15 | -0.14 | 0.04 | 0.04 | -0.03 |
| Normalized Diluted EPS | -0.03 | -0.03 | -0.03 | -0.03 | -0.03 |
| Average Basic Shares Outstanding | 107.94M | 104.48M | 85.27M | 85.21M | 82.00M |
| Average Diluted Shares Outstanding | 107.94M | 104.48M | 85.27M | 85.21M | 82.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
